Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Fagan

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|May 18, 2021
Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With CirrhosisJasmohan S Bajaj, Guadalupe Garcia-Tsao, K Rajender Reddy, et al.
Hepatology (Baltimore, Md.)|June 21, 2019
Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal TransplantRunping Liu, Jason D Kang, R Balfour Sartor, et al.
Journal of Hepatology|September 24, 2022
A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL studyAndrew Fagan, Edith A Gavis, Mary Leslie Gallagher, et al.
Alcoholism, Clinical and Experimental Research|September 20, 2017
Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut-Liver AxisJasmohan S Bajaj, Genta Kakiyama, Derrick Zhao, et al.
Digestive Diseases and Sciences|April 24, 2020
Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of FallsChathur Acharya, Melanie B White, Andrew Fagan, et al.
The American Journal of Gastroenterology|June 7, 2018
Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in CirrhosisJasmohan S Bajaj, Chathur Acharya, Andrew Fagan, et al.
Metabolic Brain Disease|June 27, 2016
Cirrhotic patients have good insight into their daily functional impairment despite prior hepatic encephalopathy: comparison with PROMIS normsJasmohan S Bajaj, Melanie B White, Ariel B Unser, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trialJasmohan S Bajaj, Zain Kassam, Andrew Fagan, et al.
Journal of Hepatology|January 12, 2025
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trialJasmohan S Bajaj, Andrew Fagan, Edith A Gavis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 4, 2018
Alterations in gut microbial function following liver transplantJasmohan S Bajaj, Genta Kakiyama, I Jane Cox, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|May 18, 2021
Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With CirrhosisJasmohan S Bajaj, Guadalupe Garcia-Tsao, K Rajender Reddy, et al.
Hepatology (Baltimore, Md.)|June 21, 2019
Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal TransplantRunping Liu, Jason D Kang, R Balfour Sartor, et al.
Journal of Hepatology|September 24, 2022
A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL studyAndrew Fagan, Edith A Gavis, Mary Leslie Gallagher, et al.
Alcoholism, Clinical and Experimental Research|September 20, 2017
Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut-Liver AxisJasmohan S Bajaj, Genta Kakiyama, Derrick Zhao, et al.
Digestive Diseases and Sciences|April 24, 2020
Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of FallsChathur Acharya, Melanie B White, Andrew Fagan, et al.
The American Journal of Gastroenterology|June 7, 2018
Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in CirrhosisJasmohan S Bajaj, Chathur Acharya, Andrew Fagan, et al.
Metabolic Brain Disease|June 27, 2016
Cirrhotic patients have good insight into their daily functional impairment despite prior hepatic encephalopathy: comparison with PROMIS normsJasmohan S Bajaj, Melanie B White, Ariel B Unser, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trialJasmohan S Bajaj, Zain Kassam, Andrew Fagan, et al.
Journal of Hepatology|January 12, 2025
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trialJasmohan S Bajaj, Andrew Fagan, Edith A Gavis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 4, 2018
Alterations in gut microbial function following liver transplantJasmohan S Bajaj, Genta Kakiyama, I Jane Cox, et al.
Pageof 12